Profile
Melanie Mahtani served as Interim CEO at Telome Health, Inc. from 2010 to 2011.
She was Vice President of Business Development at GenoSpectra, Inc. She was also Chief Geneticist at Cellscape Corp.
from 2012 to 2014.
From 2016 to 2017, she served as Chief Scientific Advisor at MaRS Discovery District (Venture Capital).
Dr. Mahtani holds an undergraduate degree from Brown University and a doctorate from Stanford University.
Former positions of Melanie Mahtani
| Companies | Position | End |
|---|---|---|
AEENA Dx, Inc.
 AEENA Dx, Inc. Medical SpecialtiesHealth Technology AEENA Dx, Inc. is a company based in Mountain View, CA. The company's description is "nowdx". Robert K. Weigle has been the CEO of the company since 2020. | Chief Operating Officer | 2021-05-31 |
MaRS Discovery District (Venture Capital)
 MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Consultant / Advisor | 2016-12-31 |
Cellscape Corp.
 Cellscape Corp. Data Processing ServicesTechnology Services Cellscape Corp. provides data analytics services. The company is based in Mountain View, CA. The company was founded by Bhairavi Parikh, Karen Ruth Drexler, James Stone. | Corporate Officer/Principal | 2014-05-31 |
| Telome Health, Inc. | Chief Executive Officer | 2010-12-31 |
GenoSpectra, Inc.
 GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Corporate Officer/Principal | - |
Training of Melanie Mahtani
| Brown University | Undergraduate Degree |
| Stanford University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
GenoSpectra, Inc.
GenoSpectra, Inc. BiotechnologyHealth Technology Genospectra, Inc. was a life science company developing technologies and products for Parallel Quantitative Biology (PQB). Genospectra's PQB initiative was focused on creating novel cell-based assays and tools that enable multiplex measurements of molecular events, such as intracellular pathway analysis, in a quantitative and scalable manner. Genospectra's first product line, the QuantiGene Reagent System was launched in 2003, and was powered by the FDA approved and proprietary branched DNA technology for gene expression analysis in cell-based assays. Genospectra was headquartered in Fremont, CA. | Health Technology |
AEENA Dx, Inc.
AEENA Dx, Inc. Medical SpecialtiesHealth Technology AEENA Dx, Inc. is a company based in Mountain View, CA. The company's description is "nowdx". Robert K. Weigle has been the CEO of the company since 2020. | Health Technology |
Cellscape Corp.
Cellscape Corp. Data Processing ServicesTechnology Services Cellscape Corp. provides data analytics services. The company is based in Mountain View, CA. The company was founded by Bhairavi Parikh, Karen Ruth Drexler, James Stone. | Technology Services |
MaRS Discovery District (Venture Capital)
MaRS Discovery District (Venture Capital) Investment ManagersFinance MaRS Discovery District (Venture Capital) is a venture capital subsidiary of MaRS Discovery District founded in 2000 by Murray McCaig. The firm is headquartered in Toronto, Canada. | Finance |
| Telome Health, Inc. |
- Stock Market
- Insiders
- Melanie Mahtani
